We developed a heteroduplex mobility assay in the gag gene (gag HMA) for the identification of group M subtypes A to H. The assay covers the region coding for amino acid 132 of p24 to amino acid 20 of p7 (according to human immunodeficiency virus type 1 [HIV-1] ELI, 460 bp). The gag HMA was compared with sequencing and phylogenetic analysis of an evaluation panel of 79 HIV-1 group M isolates isolated from infected individuals from different geographic regions. Application of gag HMA in combination with env HMA on 252 HIV-1- positive plasma samples from Bénin, Cameroon, Kenya, and Zambia revealed a high prevalence of a variety of intersubtype recombinants in Yaoundé, Cameroon (53.8%); Kisumu, Kenya (26.8%); and Cotonou, Bénin (41%); no recom...
In West and West Central Africa, multiple subtypes, circulating recombinant forms (CRF), and high pr...
Background: Detection of HIV-1 p24 antigen permits early identification of primary HIV infection and...
To halt the human immunodeficiency virus type 1 (HIV-1) epidemic requires interventions that can pre...
We developed a heteroduplex mobility assay in the gag gene (gag HMA) for the identification of group...
A multiplex DNA PCR assay was developed for the simultaneous first-round amplification of HIV-1 gag ...
A total of 343 HIV-1-positive samples obtained between June 1996 and March 1999 was genetically char...
The emergence of intersubtype recombinant HIV-1 isolates has made it imperative to analyze different...
OBJECTIVE: To describe and evaluate a simple procedure to identify HIV-1 co- or super-infections bas...
We investigated HIV-1 diversity by means of heteroduplex mobility assay (HMA) genotyping. We studied...
We have developed and validated an oligonucleotide probe hybridization assay for human immunodeficie...
A study was conducted to investigate the genetic diversity of HIV-1 in South Africa. Blood was coll...
Genomic variations in HIV-1 represent a major problem in understanding disease progression, studying...
The genetic subtype was identified in gag and env of 219 HIV-1-positive samples collected in differe...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
In West and West Central Africa, multiple subtypes, circulating recombinant forms (CRF), and high pr...
Background: Detection of HIV-1 p24 antigen permits early identification of primary HIV infection and...
To halt the human immunodeficiency virus type 1 (HIV-1) epidemic requires interventions that can pre...
We developed a heteroduplex mobility assay in the gag gene (gag HMA) for the identification of group...
A multiplex DNA PCR assay was developed for the simultaneous first-round amplification of HIV-1 gag ...
A total of 343 HIV-1-positive samples obtained between June 1996 and March 1999 was genetically char...
The emergence of intersubtype recombinant HIV-1 isolates has made it imperative to analyze different...
OBJECTIVE: To describe and evaluate a simple procedure to identify HIV-1 co- or super-infections bas...
We investigated HIV-1 diversity by means of heteroduplex mobility assay (HMA) genotyping. We studied...
We have developed and validated an oligonucleotide probe hybridization assay for human immunodeficie...
A study was conducted to investigate the genetic diversity of HIV-1 in South Africa. Blood was coll...
Genomic variations in HIV-1 represent a major problem in understanding disease progression, studying...
The genetic subtype was identified in gag and env of 219 HIV-1-positive samples collected in differe...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
The genetic diversity of group M HIV-1 is highest in west central Africa. Blood samples from four lo...
In West and West Central Africa, multiple subtypes, circulating recombinant forms (CRF), and high pr...
Background: Detection of HIV-1 p24 antigen permits early identification of primary HIV infection and...
To halt the human immunodeficiency virus type 1 (HIV-1) epidemic requires interventions that can pre...